|
已读[385]
发布： 2013/06/14 10:17:23
金星药业的主要产品为草分枝杆菌F.U.36注射液(乌体林斯),作为免疫调节剂,...埃索美拉唑是公司自主研发产品,1998年立项,2001年申报临床研究,2010年申报生产,...
|
|
|
|
|
已读[262]
发布： 2013/06/14 10:17:19
食物难以接触到味蕾,从而降低味蕾的敏感度,使味觉功能减退,消化能力也会变弱,影响味觉和食欲,最终引起挑食厌食症;锌还是强效免疫调节剂,小孩缺锌会降低身体免疫力,...
|
|
|
|
|
已读[152]
发布： 2013/06/14 10:16:55
Healio “Those on TNF-a inhibitors, both on monotherapy and on dual therapy with an immunomodulator , are at an increased risk of developing malignant solid cancers, relative to those on 5-ASA,” Derrick J. Stobaugh, BA, BS, research study coordinator at ...
|
|
|
|
|
已读[204]
发布： 2013/06/14 10:16:47
DailyFinance Laquinimod is an oral, investigational, CNS-active immunomodulator with a novel mechanism of action being developed for the treatment of relapsing-remitting multiple sclerosis (MS). Laquinimod showed efficacy in animal models for both MS and Lupus ... and more »
|
|
|
|
|
已读[209]
发布： 2013/06/14 10:16:43
Gastroenterology & Endoscopy News “Always consider a loading dose; avoid episodic dosing; consider using a concomitant immunomodulator ; administer pre-infusion hydrocortisone in infliximab recipients; and encourage Crohn's disease patients to stop smoking.” Dr. Sandborn said that ...
|
|
|
|
|
已读[162]
发布： 2013/06/14 10:16:39
The Pharma Letter Norway-based Bionor Pharma (OSE: BIONOR) saw its shares leap 16% to 3.67 kroner on June 13, after the company revealed that the first part of its phase II clinical study combining the HIV vaccine, Vacc-4x, with Celgene's immunomodulator , Revlimid ...
|
|
|
|
|
已读[243]
发布： 2013/06/13 01:58:05
可选择紫外线照射、免疫调节剂、中医中药及外用药等毒副作用较小的疗法,并根据病情调整治疗方案,将对于身体可能的伤害降到低。外用药物或外用疗法可以减少治疗对于全身...
|
|
|
|
|
已读[223]
发布： 2013/06/13 01:57:35
免疫调节剂包括免疫增强剂和免疫抑制剂两类,常见的有乙肝免疫球蛋白、乙肝疫苗、转移因子、免疫核糖核酸、卡介苗等。免疫抑制剂仅仅适用自身免疫为主的慢性肝炎患者,对...
|
|
|
|
|
已读[200]
发布： 2013/06/13 01:56:41
Healio “Those on TNF-a inhibitors, both on monotherapy and on dual therapy with an immunomodulator , are at an increased risk of developing malignant solid cancers, relative to those on 5-ASA,” Derrick J. Stobaugh, BA, BS, research study coordinator at ...
|
|
|
|
|
已读[209]
发布： 2013/06/13 01:56:35
Marketwire (press release) Laquinimod is an oral, investigational, CNS-active immunomodulator with a novel mechanism of action being developed for the treatment of relapsing-remitting multiple sclerosis (MS). Laquinimod showed efficacy in animal models for both MS and Lupus ... and more »
|
|
|
« 上一页 |
查看结果111-120共270
|
下一页 »
|
|
